PITTSBURGH - A Pittsburgh-based investment firm, iNetworks Advisors Inc., has announced a $20 million fund to invest in startup and early-stage health and life science companies in Southeast Michigan and Windsor. The fund, iNetworksMichigan Fund LP, which already has about $15 million in commitments. It also has appointed Greg Auner, director of the Smart Sensors
KALAMAZOO - A second edition of Kalamazoo Valley Community College's Patient Care Academy, which trains people for entry-level positions in the growing health-care industry while introducing them to the possibility of career enhancement in its various fields, is scheduled to begin on Oct. 2. The first academy is under way at the M-TEC located on
SWARTZ CREEK - Diplomat Specialty Pharmacy, the nation's largest privately owned specialty pharmacy, announced Monday that Robert Fleckenstein will serve as the Vice President of Operations overseeing the day-to-day operations of Diplomat's National Distribution Center, Patient Service Operations, Call Center, Oncology Department and other patient facing services at Diplomat's Corporate headquarters. Because of Fleckenstein's prior
ALLEGAN - Perrigo Tuesday announced that it has acquired the exclusive U.S. store brand rights to sell and distribute OTC versions of Fexofenadine HCl 180 mg and 60 mg tabs, plus Fexofenadine HCl 60 mg and Pseudoephedrine 120 mg tabs, the generic versions of Sanofi-Aventis' Allegra and Allegra D-12 products. Teva Pharmaceutical Industries Ltd. TEVA
LANSING ? Angott Medical Products won 2nd Place in the BioTech Awards, and $25,000, at the Great Lakes Entrepreneurs Quests awards contest. Bloomfield Hills-based Angott Medical is developing a multi-modality breast cancer test with higher sensitivity and positive predictive value than clinical breast exams. Paul Angott talks about his product in this Newsmaker interview. To
GRAND RAPIDS - Van Andel Research Institute announced that it has reached a licensing agreement for its XenoBase software system with Intervention Insights, a Grand Rapids-based company formed in 2009 with investments from more than a dozen local investors. The company was created to compete in the emerging personalized medicine industry by supporting community oncologists
ANN ARBOR - Exactly one year after purchasing a 174-acre research campus formerly used for advanced pharmaceutical development, the University of Michigan has selected the leader who will steer the site's transformation into a vibrant home for academic and private-sector research. And for that leader, it will also be a homecoming. David Canter, a physician,
YPSILANTI ? MichBio announced that Dr. Jeffrey Shuren, Director of the Center for Devices and Radiological Health at the U.S. Food and Drug Administration will keynote the 2010 MichBio Expo & Conference this October at the Marriott at Eagle Crest in Ypsilanti. "Dr. Shuren's visit will be particularly timely as the FDA's CDRH continues with
EAST LANSING ? SanoBio Therapeutics, an Ann Arbor-based biopharmaceutical company commercializing a therapeutic peptide for the treatment of diabetic ulcers, was runner up in the New Business Category at the Great Lakes Entrepreneurs Quest contest, winning $2,500. The company also picked up another $5000 from the MEDC as a biotech entrepreneur award winner. To listen,
DETROIT ? MitoStem, a Wayne State University TechTown tenant, which is developing its stem cell technology that can be used to grow many organs in the body, was awarded $5000 at the Great Lakes Entrepreneur's Quest awards ceremony by the MEDC for its excellence as a biotech entrepreneurial startup. To listen, click on MITechNews.JenesysGroup.Com a>>